title: Ciprofloxacin treatment of acute infections in immunocompromised host.
authors.affiliation: Med.-Diagn. Lab., Düsseldorf and Marienhospital Oncology, Düsseldorf, West-Germany.
authors.forename: G
authors.initials: G
authors.lastname: Nemes
authors.forename: Y
authors.initials: Y
authors.lastname: Heuser
authors.forename: D
authors.initials: D
authors.lastname: Stolle
authors.forename: H D
authors.initials: HD
authors.lastname: Piroth
authors.forename: P
authors.initials: P
authors.lastname: Nemes
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin